Long-term follow-up of efficacy and safety of selinexor maintenance treatment in patients with TP53wt advanced or recurrent endometrial cancer: A subgroup analysis of the ENGOT-EN5/GOG-3055/SIENDO study

  1. Makker, V.
  2. Perez-Fidalgo, J.A.
  3. Valabrega, G.
  4. Hamilton, E.
  5. Van Gorp, T.
  6. Sehouli, J.
  7. Regináčová, K.
  8. Richardson, D.L.
  9. Perri, T.
  10. Oza, A.M.
  11. Miller, D.S.
  12. Alía, E.M.G.
  13. De Giorgi, U.
  14. Henry, S.
  15. Spitz, D.L.
  16. Wimberger, P.
  17. Bednaříková, M.
  18. Chon, H.S.
  19. Martínez-Garcia, J.
  20. Pisano, C.
  21. Berek, J.S.
  22. Romero, I.
  23. Scambia, G.
  24. Fariñas-Madrid, L.
  25. Buscema, J.
  26. Schochter, F.
  27. Li, K.
  28. Kalyanapu, P.
  29. Walker, C.J.
  30. Vergote, I.
  31. Erakutsi egile guztiak +
Aldizkaria:
Gynecologic Oncology

ISSN: 1095-6859,  0090-8258

Argitalpen urtea: 2024

Alea: 185

Orrialdeak: 202-211

Mota: Artikulua

DOI: 10.1016/J.YGYNO.2024.05.016 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus